The impact of nonosteogenic factors on the expression of osteoprotegerin and RANKL during human fracture healing

被引:8
作者
Starlinger, J. [1 ]
Kaiser, G. [1 ]
Thomas, A. [1 ,2 ]
Sarahrudi, K. [1 ,3 ]
机构
[1] Med Univ Vienna, Gen Hosp Vienna, Dept Orthopaed & Trauma Surg, Vienna, Austria
[2] Med Univ Vienna, Gender Med Unit, Div Endocrinol & Metab, Dept Internal Med 3, Vienna, Austria
[3] Wiener Neustadt Reg & Hosp, Dept Trauma Surg, Wiener Neustadt, Austria
来源
BONE & JOINT RESEARCH | 2019年 / 8卷 / 07期
关键词
Osteoprotegerin; sRANKL; Fracture healing; Nonunion; BONE-MINERAL DENSITY; KAPPA-B LIGAND; RECEPTOR ACTIVATOR; CIRCULATING OSTEOPROTEGERIN; SERUM OSTEOPROTEGERIN; AGE; TESTOSTERONE; ESTROGEN; SMOKING; OPG;
D O I
10.1302/2046-3758.87.BJR-2018-0116.R3
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Objectives The osteoprotegerin (OPG) and receptor activator of nuclear factor kappa-B ligand (RANKL) balance is of the utmost importance in fracture healing. The aim of this study was therefore to investigate the impact of nonosteogenic factors on OPG and RANKL levels. Methods Serum obtained from 51 patients with long bone fractures was collected over 48 weeks. The OPG and serum sRANKL (soluble RANKL) concentrations were measured using enzyme-linked immunosorbent assay (ELISA). Smoking habit, diabetes, and alcohol consumption were recorded. Results Age and sex greatly influenced preoperative serum levels of OPG and sRANKL but differences were even more pronounced during fracture healing. Statistical significance was observed for overall serum levels of OPG (p = 0.001) and sRANKL (p < 0.001) in older men and women (age greater than 50 years). Interestingly, OPG levels increased over time in older women but decreased over time in older men. Conclusion These data suggest that nonosteogenic factors, most significantly age and sex, have a major impact on sRANKL and OPG levels. Given the established association of OPG and sRANKL levels and nonunion, these findings seem to be of clinical relevance.
引用
收藏
页码:349 / 356
页数:8
相关论文
共 35 条
  • [1] Denosumab Treatment in Postmenopausal Women with Osteoporosis Does Not Interfere with Fracture-Healing Results from the FREEDOM Trial
    Adami, Silvano
    Libanati, Cesar
    Boonen, Steven
    Cummings, Steven R.
    Ho, Pei-Ran
    Wang, Andrea
    Siris, Ethel
    Lane, Joseph
    [J]. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2012, 94A (23) : 2113 - 2119
  • [2] The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts
    Bord, S
    Ireland, DC
    Beavan, SR
    Compston, JE
    [J]. BONE, 2003, 32 (02) : 136 - 141
  • [3] Knockout of toll-like receptor-4 attenuates the pro-inflammatory state of diabetes
    Devaraj, Sridevi
    Tobias, Peter
    Jialal, Ishwarlal
    [J]. CYTOKINE, 2011, 55 (03) : 441 - 445
  • [4] A unified theory of bone healing and nonunion
    Elliott, D. S.
    Newman, K. J. H.
    Forward, D. P.
    Hahn, D. M.
    Ollivere, B.
    Kojima, K.
    Handley, R.
    Rossiter, N. D.
    Wixted, J. J.
    Smith, R. M.
    Moran, C. G.
    [J]. BONE & JOINT JOURNAL, 2016, 98B (07) : 884 - 891
  • [5] Gerstenfeld L. C., 2003, Journal of Musculoskeletal & Neuronal Interactions, V3, P297
  • [6] Gerstenfeld LC, 2009, J BONE MINER RES, V24, P196, DOI [10.1359/jbmr.081113, 10.1359/JBMR.081113]
  • [7] Gori F, 2000, ENDOCRINOLOGY, V141, P4768, DOI 10.1210/en.141.12.4768
  • [8] Hawa Gerhard, 2003, Clin Lab, V49, P461
  • [9] Regulation of osteoprotegerin production by androgens and anti-androgens in human osteoblastic lineage cells
    Hofbauer, LC
    Hicok, KC
    Chen, D
    Khosla, S
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2002, 147 (02) : 269 - 273
  • [10] Serum osteoprotegerin and its relationship with bone mineral density and markers of bone turnover
    Indridason, OS
    Franzson, L
    Sigurdsson, G
    [J]. OSTEOPOROSIS INTERNATIONAL, 2005, 16 (04) : 417 - 423